Leigh Morgan's most recent trade in Kymera Therapeutics Inc was a trade of 16,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Leigh Morgan | Director | 18 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | ||
| Kymera Therapeutics Inc | Leigh Morgan | Director | 15 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | ||
| Kymera Therapeutics Inc | Leigh Morgan | Director | 06 Jul 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) |